RES CANCER INSTITUTE OF AMERICA has a total of 18 patent applications. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are PERIOC LTD, MOONSHOT PHARMA LLC and BEXION PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Australia | 2 | |
#5 | China | 1 | |
#6 | Japan | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Nanostructure applications | |
#5 | Physical therapy devices | |
#6 | Operating tables |
# | Name | Total Patents |
---|---|---|
#1 | Nezami Mohammed Amin | 9 |
#2 | Nezami Md Mohammad | 5 |
#3 | Mohammad Nezami Md | 1 |
#4 | Nezami Mohammed | 1 |
#5 | Nezami Mohammad Md | 1 |
#6 | Nezami Mohammad Amin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019099750A1 | Compositions, methods, systems and/or kits for preventing and/or treating neoplasms | |
WO2019071229A1 | Compositions, methods, systems and/or kits for preventing and/or treating neoplasms | |
WO2018170457A1 | Compositions, methods, systems and/or kits for preventing and/or treating neoplasms | |
WO2018157081A1 | Compositions, methods, systems and/or kits for preventing and/or treating neoplasms | |
US2017007573A1 | Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances | |
CN109675041A | System, method and formulation for treating cancer |